logo-loader
viewFeedback PLC

Feedback in discussions about pilot schemes for Bleepa app

The app was unveiled at the NHS Expo in September.

Feedback PLC - Feedback in discussions about pilot schemes for Bleepa app
A strategic review of biomarker identifier software TexRAD is ongoing

Feedback PLC(LON:FEED) says it is considering numerous opportunities for its medical imaging app Bleepa following its recent launch.

Advanced discussions are underway with NHS pilot sites and the company hopes to start some of these schemes shortly.

Bleepa is an encrypted and secure way for doctors to send images of X-ray and other scans each other to aid diagnosis and treatment.

The app was unveiled at the NHS Expo in September.

Tom Oakley, Feedback’s chief executive, said: "We are very encouraged by the response to Bleepa having discussed this with senior NHS executives and clinicians at NHS Expo.

“The feedback that we have received is that Bleepa clearly has applications across the healthcare sector, not only in individual hospital settings but also in community and cross site clinical settings.

Feedback added that its strategic review of biomarker identifier software TexRAD is ongoing and it hopes to have it completed by the end of the year.

Quick facts: Feedback PLC

Price: 0.8 GBX

LSE:FDBK
Market: LSE
Market Cap: £4.32 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Feedback PLC named herein, including the promotion by the Company of Feedback PLC in any Content on the Site, the Company receives from said...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Feedback PLC 'on the right trajectory' as it looks to...

Feedback PLC's (LON:FDBK) CEO Tom Oakley speaks to Proactive London's Andrew Scott soon after the release of its interim results to November 2019. Oakley says the big focus for them currently is to convert the results of a pilot study of its new app Bleepa for doctors into “meaningful...

2 days, 5 hours ago

2 min read